Position in TMO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,010,880
-$904,420 QoQ
Shares Held
8,000
-20.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#916
of 2,606 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Derivatives in TMO
reported options exposure · as of Jun 30, 2026CallValue
$2,506,800
CallShares
5,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026KP Management LLC holds $4,010,880 across 1 Diagnostics & Research name. TMO ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
8,000 | $4,010,880 |
All Filings in TMO
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,010,880 | 8,000 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $2,506,800 | 5,000 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $4,915,300 | 10,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,794,500 | 10,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,850,200 | 10,000 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $4,976,000 | 10,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,722,530 | 11,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,804,270 | 11,000 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $6,083,000 | 11,000 | Shares | Sole | 2024-09-19 | |
| 2024-03-31 | $6,393,310 | 11,000 | Shares | Sole | 2024-09-19 | |
| 2023-12-31 | $1,592,370 | 3,000 | Call | Sole | 2024-09-19 | |
| 2023-12-31 | $5,838,690 | 11,000 | Shares | Sole | 2024-09-19 | |
| No filing history on record for this holder in this stock. | ||||||